A PSAP motif in the ORF3 protein of hepatitis E virus is necessary for virion release from infected cells

Journal of General Virology

Volumn 92, Issue 2, 2011, Pages 269-278

  Nagashima, Shigeo ^a   Takahashi, Masaharu ^a   Jirintai, ^a   Tanaka, Toshinori ^a   Yamada, Kentaro ^a   Nishizawa, Tsutomu ^a   Okamoto, Hiroaki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; OPEN READING FRAME 3 PROTEIN; PROLINE; SERINE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; GENOTYPE; HEPATITIS E VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN MOTIF; SEQUENCE ANALYSIS; VIRION; VIRUS RELEASE;

AMINO ACID SEQUENCE; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; GENETIC VARIATION; HEPATITIS E VIRUS; HEPATOCYTES; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ALIGNMENT; VIRAL PROTEINS; VIRUS RELEASE;

HEPATITIS E VIRUS;

EID: 79251485981     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.025791-0     Document Type: Article

References (34)

1. Agrawal, S., Gupta, D. & Panda, S. K. (2001). The 3′ end of hepatitis E virus (HEV) genome binds specifically to the viral RNA-dependent RNA polymerase (RdRp). Virology 282, 87-101.
2. Bilic, I., Jaskulska, B., Basic, A., Morrow, C. J. & Hess, M. (2009). Sequence analysis and comparison of avian hepatitis E viruses from Australia and Europe indicate the existence of different genotypes. J Gen Virol 90, 863-873.
3. Bouamr, F., Melillo, J. A., Wang, M. Q., Nagashima, K., de Los Santos, M., Rein, A. & Goff, S. P. (2003). PPPYVEPTAP motif is the late domain of human T-cell leukemia virus type 1 Gag and mediates its functional interaction with cellular proteins Nedd4 and Tsg101. J Virol 77, 11882-11895.
4. Chandra, V., Kar-Roy, A., Kumari, S., Mayor, S. & Jameel, S. (2008). The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and acute-phase response. J Virol 82, 7100-7110.
5. Ciancanelli, M. J. & Basler, C. F. (2006). Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J Virol 80, 12070-12078.
6. Emerson, S. U. & Purcell, R. H. (2006). Hepatitis E virus. In Fields Virology, 5th edn, pp. 3047-3058. Edited by D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman & S. E. Straus. Philadelphia: Lippincott, Williams & Wilkins.
7. Emerson, S. U., Nguyen, H. T., Torian, U., Burke, D., Engle, R. & Purcell, R. H. (2010). Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on ORF3 protein and requires an intact PXXP motif. J Virol 84, 9059-9069.
8. Garrus, J. E., von Schwedler, U. K., Pornillos, O. W., Morham, S. G., Zavitz, K. H., Wang, H. E., Wettstein, D. A., Stray, K. M., Côté, M. & other authors (2001). Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107, 55-65.
9. Göttlinger, H. G., Dorfman, T., Sodroski, J. G. & Haseltine, W. A. (1991). Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci U S A 88, 3195-3199.
10. Graff, J., Torian, U., Nguyen, H. & Emerson, S. U. (2006). A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus. J Virol 80, 5919-5926.
11. Harrison, T. J. (1999). Hepatitis E virus - an update. Liver 19, 171-176.
12. Harty, R. N., Paragas, J., Sudol, M. & Palese, P. (1999). A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J Virol 73, 2921-2929.
13. Harty, R. N., Brown, M. E., Wang, G., Huibregtse, J. & Hayes, F. P. (2000). A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc Natl Acad Sci U S A 97, 13871-13876.
14. Kabrane-Lazizi, Y., Meng, X. J., Purcell, R. H. & Emerson, S. U. (1999). Evidence that the genomic RNA of hepatitis E virus is capped. J Virol 73, 8848-8850.
15. Koonin, E. V., Gorbalenya, A. E., Purdy, M. A., Rozanov, M. N., Reyes, G. R. & Bradley, D. W. (1992). Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Proc Natl Acad Sci U S A 89, 8259-8263.
16. Lorenzo, F. R., Tanaka, T., Takahashi, H., Ichiyama, K., Hoshino, Y., Yamada, K., Inoue, J., Takahashi, M. & Okamoto, H. (2008). Mutational events during the primary propagation and consecutive passages of hepatitis E virus strain JE03-1760F in cell culture. Virus Res 137, 86-96.
17. Martin-Serrano, J., Zang, T. & Bieniasz, P. D. (2001). HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med 7, 1313-1319.
18. Meng, X. J. (2010). Recent advances in hepatitis E virus. J Viral Hepat 17, 153-161.
19. Okamoto, H. (2007). Genetic variability and evolution of hepatitis E virus. Virus Res 127, 216-228.
20. Okamoto, H., Imai, M., Usuda, S., Tanaka, E., Tachibana, K., Mishiro, S., Machida, A., Nakamura, T., Miyakawa, Y. & other authors (1985). Hemagglutination assay of polypeptide coded by the pre-S region of hepatitis B virus DNA with monoclonal antibody: correlation of pre-S polypeptide with the receptor for polymerized human serum albumin in serums containing hepatitis B antigens. J Immunol 134, 1212-1216.
21. Okamoto, H., Takahashi, M. & Nishizawa, T. (2003). Features of hepatitis E virus infection in Japan. Intern Med 42, 1065-1071.
22. Sasaki, J., Kusuhara, Y., Maeno, Y., Kobayashi, N., Yamashita, T., Sakae, K., Takeda, N. & Taniguchi, K. (2001). Construction of an infectious cDNA clone of Aichi virus (a new member of the family Picornaviridae) and mutational analysis of a stem-loop structure at the 5′ end of the genome. J Virol 75, 8021-8030.
23. Surjit, M., Oberoi, R., Kumar, R. & Lal, S. K. (2006). Enhanced α1 microglobulin secretion from hepatitis E virus ORF3-expressing human hepatoma cells is mediated by tumor susceptibility gene 101. J Biol Chem 281, 8135-8142.
24. Takahashi, M., Tanaka, T., Azuma, M., Kusano, E., Aikawa, T., Shibayama, T., Yazaki, Y., Mizuo, H., Inoue, J. & other authors (2007). Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system. J Clin Microbiol 45, 3671-3679.
25. Takahashi, M., Hoshino, Y., Tanaka, T., Takahashi, H., Nishizawa, T. & Okamoto, H. (2008a). Production of monoclonal antibodies against hepatitis E virus capsid protein and evaluation of their neutralizing activity in a cell culture system. Arch Virol 153, 657-666.
26. Takahashi, M., Yamada, K., Hoshino, Y., Takahashi, H., Ichiyama, K., Tanaka, T. & Okamoto, H. (2008b). Monoclonal antibodies raised against the ORF3 protein of hepatitis E virus (HEV) can capture HEV particles in culture supernatant and serum but not those in feces. Arch Virol 153, 1703-1713.
27. Takahashi, M., Tanaka, T., Takahashi, H., Hoshino, Y., Nagashima, S., Jirintai, Mizuo, H., Yazaki, Y., Takagi, T. & other authors (2010). Hepatitis E virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation. J Clin Microbiol 48, 1112-1125.
28. Tam, A. W., Smith, M. M., Guerra, M. E., Huang, C. C., Bradley, D. W., Fry, K. E. & Reyes, G. R. (1991). Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185, 120-131.
29. Tanaka, T., Takahashi, M., Kusano, E. & Okamoto, H. (2007). Development and evaluation of an efficient cell-culture system for hepatitis E virus. J Gen Virol 88, 903-911.
30. Tanaka, T., Takahashi, M., Takahashi, H., Ichiyama, K., Hoshino, Y., Nagashima, S., Mizuo, H. & Okamoto, H. (2009). Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patient. J Clin Microbiol 47, 1906-1910.
31. Wirblich, C., Bhattacharya, B. & Roy, P. (2006). Nonstructural protein 3 of bluetongue virus assists virus release by recruiting ESCRT-I protein Tsg101. J Virol 80, 460-473.
32. Worm, H. C., van der Poel, W. H. & Brandstatter, G. (2002). Hepatitis E: an overview. Microbes Infect 4, 657-666.
33. Yamada, K., Takahashi, M., Hoshino, Y., Takahashi, H., Ichiyama, K., Nagashima, S., Tanaka, T. & Okamoto, H. (2009a). ORF3 protein of hepatitis E virus is essential for virion release from infected cells. J Gen Virol 90, 1880-1891.
34. Yamada, K., Takahashi, M., Hoshino, Y., Takahashi, H., Ichiyama, K., Tanaka, T. & Okamoto, H. (2009b). Construction of an infectious cDNA clone of hepatitis E virus strain JE03-1760F that can propagate efficiently in cultured cells. J Gen Virol 90, 457-462.